Pepdox
Studies
Peptides
Calculator
Comparative Efficacy and Safety of Resmetirom Versus Semaglutide in Treating MASH and MASLD: A Network Meta-Analysis. | Pepdox
Home
/
Search
/
PMID 39297757
Comparative Efficacy and Safety of Resmetirom Versus Semaglutide in Treating MASH and MASLD: A Network Meta-Analysis.
American journal of therapeutics
2025
PMID: 39297757
View on PubMed
DOI: 10.1097/MJT.0000000000001808
Semaglutide
Authors
Ayesh, Hazem